Patrick Frayssinet

World Vaccine Congress Washington Speaker Interview: Dr Patrick Frayssinet

|| Dr Patrick Frayssinet, R&D Director, URODELIA We have interviewed a few of the speakers from World Vaccine Congress Washington, taking place on 10-12 April 2017 in Grand Hyatt Washington. This is the 1st of the interview series, stay connected for more. Q1: The most promise opportunities in the veterinary vaccines space are? A: One of the most promise opportunities …

ViE Awards 2016 – Voting is now open!

After weeks of voting and over 1000 nominations collected, we are happy to announce the highly nominated companies in each category as voted by you and your peers for the 9th annual Vaccine Industry Excellence (ViE) Awards in the following categories Best Clinical Trial Site AND Network Best Contract Research Organization Best Contract Manufacturing Organization Best Production/Process Development  Best Academic Research Team …

CFDA approves production of the first Sabin IPV

China Food and Drug Administration (CFDA) has approved the production of the first inactivated poliomyelitis vaccine made from inactivated Sabin strains (Sabin IPV). It was researched and developed by the Institute of Medical Biology, Chinese Academy of Medical Sciences. Poliomyelitis, often called polio or infantile paralysis, is an infectious disease caused by the poliovirus. It is a virus-transmitted disease that …

Korea’s vaccine manufacturers gain additional support

Good news for Korean vaccine manufacturers—the Korean Ministry of Food and Drug Safety (MFDS), formerly known as Korea Food & Drug Administration (KFDA), shared its plans to further support the domestic vaccine developers and boost their global market share. By growing its WHO pre-qualification counseling and consulting arm, local vaccine manufacturers will be aided with higher chances to obtain WHO …

Cancer vaccine trial in Singapore shows promising signs of success

A cancer vaccine suitable for lung, breast, prostate, colon and ovarian cancer has shown promising results in a vaccine trial conducted in Singapore. It was tested for the first time on four patients with Stage 4 cancer and no major side effects have been observed yet. The vaccine trial was launched by the National Cancer Centre of Singapore in September …

Ebola Hemorrhagic Fever, www.CDC.gov

Looming Pressure on Pharma as the Spread of Ebola Continues

When will a vaccine become available for Ebola? Killing over 8,000 people in West Africa since last year and still spreading, the need for a prophylactic Ebola vaccine is becoming increasingly important. Companies are racing to bring a safe vaccine to market and with the current pace of the epidemic in Liberia, Sierra Leone and Guinea, the demand for Ebola …

ebola vaccine bigpharma

Is the WHO Blaming BigPharma for Ebola?

No. They’re blaming governments for not investing. WHO Director General, Dr. Margaret Chan, said on Monday that the lack of an Ebola vaccine is due to Ebola historically being confined to poor ‘African nations. At the regional committee for Africa in Benin on Monday, Dr. Chan, Director general of the World Health Organization, said that  ‘Ebola emerged nearly four decades …

Two former Merck scientists have filed lawsuits against the company for misrepresenting efficacy results of its mumps vaccine

Whistleblowers Reveal Merck Misrepresented Mumps Vaccine Efficacy

Two former Merck scientists have filed lawsuits against the company for misrepresenting efficacy results of its mumps vaccine Two former virologists for Merck have filed lawsuits against the company for misrepresenting efficacy results of its mumps vaccine. A US district judge from Pennsylvania, Darnell Jones II, has ruled that the pair of whistleblowers have provided enough evidence to begin a …

Safety sweep of the NIH reveals presence of five dangerous toxic samples

NIH Finds Unauthorised Toxic Samples In Safety Sweep

Safety sweep of the NIH reveals presence of five dangerous toxic samples In July 2014, a number of unauthorised smallpox samples were discovered at the NIH’s headquarters in Bethseda, Maryland. This discovery spurred on a safety sweep of the NIH headquarters to verify the presence of any other unauthorised biological samples and toxins. On the 5th of September, it was …